Retractable Technologies, Inc. (NYSE:RVP) CEO Thomas J. Shaw Purchases 12,445 Shares of Stock

Retractable Technologies, Inc. (NYSE:RVP) CEO Thomas J. Shaw acquired 12,445 shares of the company’s stock in a transaction on Monday, January 27th. The stock was purchased at an average cost of $0.81 per share, for a total transaction of $10,080.45. Following the completion of the purchase, the chief executive officer now directly owns 15,019,308 shares in the company, valued at $12,165,639.48. This trade represents a 0.08 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

Retractable Technologies Stock Performance

NYSE RVP opened at $0.80 on Wednesday. The business’s 50 day moving average is $0.68 and its two-hundred day moving average is $0.82. Retractable Technologies, Inc. has a 12-month low of $0.56 and a 12-month high of $1.34. The company has a current ratio of 8.57, a quick ratio of 5.92 and a debt-to-equity ratio of 0.01.

Analyst Ratings Changes

Separately, StockNews.com initiated coverage on shares of Retractable Technologies in a report on Wednesday, January 22nd. They issued a “hold” rating on the stock.

Institutional Trading of Retractable Technologies

A hedge fund recently bought a new stake in Retractable Technologies stock. PFG Investments LLC bought a new stake in Retractable Technologies, Inc. (NYSE:RVP) in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned approximately 0.12% of Retractable Technologies at the end of the most recent quarter. 7.58% of the stock is currently owned by institutional investors.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.